Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-β

被引:14
|
作者
Puissant-Lubrano, Benedicte [1 ,2 ]
Viala, Frederique
Winterton, Peter [2 ]
Abbal, Michel [1 ,2 ]
Clanet, Michel
Blancher, Antoine [1 ,2 ]
机构
[1] CHU Toulouse, Hop Rangueil, Immunol Lab, F-31059 Toulouse 9, France
[2] Univ Toulouse 3, Fac Med Toulouse Rangueil, Immunogenet Mol Lab, F-31062 Toulouse 4, France
关键词
multiple sclerosis; thymic function; regulatory T cells; IFN-beta treatment; T cell subsets; CD45RC;
D O I
10.1016/j.jneuroim.2007.10.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We explored the parameters of central and peripheral tolerance in patients with stable relapsing-remitting multiple sclerosis, treated or not with IFN-beta TREC-positive T cells were lower in patients compared with controls, mainly in CD4+ subset, compatible with a thymus dysfunction or an expansion of peripheral lymphocytes. Compared to controls, the frequency of activated CD4+CD25+ T cells was higher in patients without modification of the CD4+CD25(high) T cell proportion. The IFN-beta-treatment did not modify the TREC-positive cell frequency nor the naive/memory T cell subset percentage but was associated with lower blood lymphocyte count and a lower frequency of CD4+CD45RC(high) subset. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 50 条
  • [21] Peripheral oxidative stress in relapsing-remitting multiple sclerosis
    Tasset, Inmaculada
    Aguelera, Eduardo
    Sanchez-Lopez, Fernando
    Feijoo, Montserrat
    Giraldo, Ana I.
    Cruz, Antonio H.
    Gascon, Felix
    Tunez, Isaac
    CLINICAL BIOCHEMISTRY, 2012, 45 (06) : 440 - 444
  • [22] Apoptosis of peripheral blood lymphocytes in patients with relapsing-remitting multiple sclerosis
    Petelin, Z
    Brinar, V
    Petravic, D
    Zurak, N
    Dubravcic, K
    Batinic, D
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S172 - S173
  • [23] Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
    Doehler, N.
    Mueller, S.
    Vehoff, J.
    Galovic, M.
    Tettenborn, B.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 213
  • [24] Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis
    Boppana, Sridhar
    Mindur, John E.
    Balashov, Konstantin E.
    Dhib-Jalbut, Suhayl
    Ito, Kouichi
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 265 (1-2) : 68 - 74
  • [25] The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients
    Shajarian, Mansour
    Alsahebfosoul, Fereshteh
    Etemadifar, Masoud
    NEUROIMMUNOMODULATION, 2021, 28 (03) : 150 - 157
  • [26] HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis
    Mazdeh, Mehrdokht
    Taheri, Mohammad
    Sayad, Arezou
    Bahram, Siamak
    Omrani, Mir Davood
    Movafagh, Abolfazl
    Inoko, Hidetoshi
    Akbari, Mohammad Taghi
    Noroozi, Rezvan
    Hajilooi, Mehrdad
    Solgi, Ghasem
    PHARMACOGENOMICS, 2016, 17 (05) : 489 - 498
  • [27] T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients
    Achiron, A
    Lavie, G
    Kishner, I
    Stern, Y
    Sarova-Pinhas, I
    Ben-Aharon, T
    Barak, Y
    Raz, H
    Lavie, M
    Barliya, T
    Faibel, M
    Cohen, IR
    Mandel, M
    CLINICAL IMMUNOLOGY, 2004, 113 (02) : 155 - 160
  • [28] Heterogeneity of peripheral blood NK cells behaviour in relapsing-remitting multiple sclerosis patients treated with dimethylfumarate
    Marastoni, D.
    Magliozzi, R.
    Pitteri, M.
    Crescenzo, F.
    Zuco, C.
    Rossi, S.
    Castellaro, M.
    Farina, G.
    Monaco, S.
    Calabrese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 605 - 606
  • [29] Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis
    D'Amico, Emanuele
    Zanghi, Aurora
    Parrinello, Nunziatina Laura
    Romano, Alessandra
    Palumbo, Giuseppe Alberto
    Chisari, Clara Grazia
    Toscano, Simona
    Raimondo, Francesco Di
    Zappia, Mario
    Patti, Francesco
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Circulating lymphocyte levels and relationship with infection status in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta
    Giovannoni, Gavin
    Wiendl, Heinz
    Turner, Benjamin
    Umans, Kimberly
    Mokliatchouk, Oksana
    Castro-Borrero, Wanda
    Greenberg, Steven J.
    McCroskery, Peter
    Giannattasio, Giorgio
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (13) : 1725 - 1736